Skip to main content

Gilead's hepatitis C 'cure' moves ahead at FDA

A kinder, gentler hepatitis C treatment from Gilead Sciences Inc. — seen as a potential cure for the debilitating and deadly liver disease — was green-lighted Friday by an FDA advisory panel...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.